NeuroOne Medical Stock (NASDAQ:NMTC)
Previous Close
$0.76
52W Range
$0.55 - $1.72
50D Avg
$0.81
200D Avg
$0.92
Market Cap
$22.88M
Avg Vol (3M)
$151.28K
Beta
0.91
Div Yield
-
NMTC Company Profile
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.
NMTC Performance
Peer Comparison
| Ticker | Company |
|---|---|
| MOVE | Movano Inc. |
| BSGM | BioSig Technologies, Inc. |
| NPCE | NeuroPace, Inc. |
| SRDX | Surmodics, Inc. |
| BMRA | Biomerica, Inc. |
| NSYS | Nortech Systems Incorporated |
| LNSR | LENSAR, Inc. |
| SSKN | STRATA Skin Sciences, Inc. |
| DCTH | Delcath Systems, Inc. |
| XAIR | Beyond Air, Inc. |
| BBLG | Bone Biologics Corporation |
| HSCS | Heart Test Laboratories, Inc. |
| TNON | Tenon Medical, Inc. |
| CVRX | CVRx, Inc. |